Evaluación antibacteriana de extracto y aceite esencial de Pumamaqui (Oreopanax ecuadorensis Seeman) FRENTE A: ( Staphylococcus aureus ATCC: 25923, Streptococcus pyogenes ATCC: 19615, Streptococcus pneumoniae ATCC: 49619 y Streptococcus mutans ATCC: 25175), patógenos de enfermedades respiratorias
The main objective of this project work is to evaluate the antibacterial activity of the essential oil and fluid extract of Oreopanax ecuadorensis Seeman. It was used the essential oil of the vegetal specie obtained by duct diffusion and they were performed dilutions of the same with DMSO, wor...
| Autor Principal: | González Sánchez, Andrés Rafael |
|---|---|
| Formato: | bachelorThesis |
| Idioma: | spa |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: |
http://dspace.ups.edu.ec/handle/123456789/12534 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: |
The main objective of this project work is to evaluate the antibacterial activity of
the essential oil and fluid extract of Oreopanax ecuadorensis Seeman. It was used
the essential oil of the vegetal specie obtained by duct diffusion and they were
performed dilutions of the same with DMSO, working with the next
concentrations (5%, 2.5% and 1.25%), also was evaluated the activity of the fluid
extract at 25% of concentration performed by percolation.
The duct diffusion technique was made with different concentration levels of
essential oil and only one concentration of fluid extract compared to:
Staphylococcus aureus ATCC: 25923, Streptococcus mutans ATCC: 25175,
Streptococcus pneumoniae ATCC: 49619 y Streptococcus pyogenes ATCC:
19615, those bacteria considered as representative as principal pathogens of
respiratory diseases. Based on the results and the statistical analysis it could be
concluded that Oreopanax ecuadorensis Seeman, with the 25% of concentration
by the extract presented inhibitory activity in front of Streptococcus pyogenes
ATCC 19615 with 12.1 mm, follow of Streptococcus mutans ATCC 25175 with
10.9 mm and 10.4 mm to Streptococcus pneumoniae ATCC 49619, while not
evidenced inhibitory activity in front of Staphylococcus aureus ATCC 25923.
Whereas the essential oil presents in the 5%, 2.5% and 1.25% concentrations
values of 6 mm of diameter of inhibition to: Staphylococcus aureus ATCC 25923,
Streptococcus mutans ATCC 25175, Streptococcus pneumoniae ATCC 49619,
and y Streptococcus pyogenes ATCC 19615. |
|---|